| Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives M Abdul-Latif, K Townsend, C Dearman, KK Shiu, K Khan Cancer Treatment Reviews 88, 102030, 2020 | 55 | 2020 |
| Checkpoint inhibitor treatment in patients with isolated in-transit melanoma metastases. L Storey, M Abdul-Latif, S Kreft, E Barrett, LM Pickering, MW Rohaan, ... Journal of Clinical Oncology 38 (15_suppl), 10070-10070, 2020 | 6 | 2020 |
| Functional Magnetic Resonance Imaging in Cervical Cancer Diagnosis and Treatment M Abdul-Latif, H Tharmalingam, Y Tsang, PJ Hoskin Clinical Oncology 35 (9), 598-610, 2023 | 2 | 2023 |
| Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution … S Armstrong, A Makris, K Belessiotis-Richards, M Abdul-Latif, P Ostler, ... Clinical Oncology 36 (6), 362-369, 2024 | | 2024 |
| Salvage brachytherapy for second ipsilateral breast tumor event: Relating dosimetric analysis to late side effects M Abdul-Latif, J Gal, R Schiappa, Y Rizzi, M Gautier, JM Hannoun-Levi Brachytherapy 23 (3), 335-341, 2024 | | 2024 |
| Exploratory study of using Magnetic resonance Prognostic Imaging markers for Radiotherapy In Cervix cancer (EMPIRIC): a prospective cohort study protocol M Abdul-Latif, A Chowdhury, H Tharmalingam, NJ Taylor, A Lakhani, ... BMJ open 14 (4), e077390, 2024 | | 2024 |
| PO-1410 Dosimetry predictors for haematological toxicity in chemoradiotherapy for cervical cancer M Abdul-Latif, J Perera, H Tharmalingam, Y Tsang, P Hoskin Radiotherapy and Oncology 182, S1139-S1141, 2023 | | 2023 |
| Combining the Best of Both Worlds: The Role of Sequential Stereotactic Radiotherapy Boost for Spinal Metastases J Sherriff, M Abdul-Latif, YM Tsang Clinical Oncology 35 (5), 323-325, 2023 | | 2023 |
| Definitive chemoradiotherapy in oesophageal cancer: treatment outcomes from a regional cancer centre M Abdul-Latif, N Bhuva, M Harrison, R Glynne-Jones Annals of Oncology 30, iv33-iv34, 2019 | | 2019 |
| Upfront Docetaxel in the Post-STAMPEDE Era–An Analysis of Treatment Population, Toxicities and Outcomes M Abdul-Latif, A Macdonald, K Ng, C Alifrangis, J Shamash Clinical Oncology 31 (2), e22, 2019 | | 2019 |
